Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Study protocol

Detecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine

Authors: Jingsheng Guo, Dongye Li, Shiru Bai, Tongda Xu, Zhongmin Zhou, Yanbin Zhang

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Neointimal formation plays an important role in the pathogenesis of coronary restenosis after percutaneous coronary intervention (PCI), especially in patients with diabetes mellitus. Recently, some studies have shown that 5-ethynyl-2'-deoxyuridine (EdU) incorporation can serve as a novel alternative to the 5-bromo-2'-deoxyuridine (BrdU) antibody detection method for detection of DNA synthesis in regenerating avian cochlea, chick embryo and the adult nervous system. However, few studies have been performed to assess the suitability of EdU for detecting DNA synthesis in vascular neointima.

Methods

The carotid artery balloon injury model was established in Goto-Kakizaki (GK) and Wistar rats. A Cell-LightTM EdU Kit was used to detect EdU-labeled cell nuclei of common carotid arteries at day 7 after catheter balloon injury. Different methods of injecting EdU were tested. The protein levels of proliferating cell nuclear antigen (PCNA) and p-Akt (Ser473), as well as the mRNA levels of PCNA were evaluated by Western blotting and quantitative real-time PCR (qRT-PCR), respectively. Immunohistochemical staining was also employed to visualize PCNA-positive cells.

Results

At day 7 after catheter balloon injury, far more EdU-positive and PCNA-positive cells were observed in GK rats. When comparing groups that received different EdU doses, it was found that the percentage of EdU-positive cells at a dose of 100 mg/kg body weight was than at doses of 25 mg/kg and 50 mg/kg. The number of positive cells was significantly higher in the repeated injection group compared to the single injection group. Further, after balloon injury DNA synthesis in GK rats was more notable than in Wistar rats. Neointimal formation in GK rats was more obvious than in Wistar rats. The protein levels of PCNA and p-Akt (Ser473) and the mRNA levels of PCNA were increased in injured rats as compared to uninjured rats, and were significantly higher in GK rats than in Wistar rats.

Conclusion

By intraperitoneal injections of EdU at a dose of 100 mg/kg three times, EdU incorporation can detect carotid arterial DNA synthesis caused by neointimal formation in GK rats and Wistar rats at day 7 after balloon injury by the EdU click reaction quickly and effectively. Moreover, more obvious DNA synthesis in the vascular neointima could be observed in GK rats than in Wistar rats.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yang TH, Park SW, Hong MK, Park DW, Park KM, Kim YH, Han KH, Lee CW, Cheong SS, Kim JJ, Park SJ: Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. Am J Cardiol. 2005, 96 (10): 1389-1392. 10.1016/j.amjcard.2005.07.043.CrossRefPubMed Yang TH, Park SW, Hong MK, Park DW, Park KM, Kim YH, Han KH, Lee CW, Cheong SS, Kim JJ, Park SJ: Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. Am J Cardiol. 2005, 96 (10): 1389-1392. 10.1016/j.amjcard.2005.07.043.CrossRefPubMed
2.
go back to reference Park DW, Flaherty JD, Davidson CJ, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ: Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in asian patients. Am J Cardiol. 2009, 103 (5): 646-652. 10.1016/j.amjcard.2008.11.012.CrossRefPubMed Park DW, Flaherty JD, Davidson CJ, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ: Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in asian patients. Am J Cardiol. 2009, 103 (5): 646-652. 10.1016/j.amjcard.2008.11.012.CrossRefPubMed
3.
go back to reference Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, Ibrahim M, Schömig A, Kastrati A: Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J. 2007, 154 (4): 688-693. 10.1016/j.ahj.2007.06.005.CrossRefPubMed Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, Ibrahim M, Schömig A, Kastrati A: Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J. 2007, 154 (4): 688-693. 10.1016/j.ahj.2007.06.005.CrossRefPubMed
4.
go back to reference Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW: Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004, 109 (19): 2273-2278. 10.1161/01.CIR.0000129767.45513.71.CrossRefPubMed Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW: Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004, 109 (19): 2273-2278. 10.1161/01.CIR.0000129767.45513.71.CrossRefPubMed
5.
go back to reference Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW, TAXUS-IV Investigators: Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005, 45 (8): 1172-1179. 10.1016/j.jacc.2004.10.075.CrossRefPubMed Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW, TAXUS-IV Investigators: Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005, 45 (8): 1172-1179. 10.1016/j.jacc.2004.10.075.CrossRefPubMed
6.
go back to reference Sheehy A, Hsu S, Bouchard A, Lema P, Savard C, Guy LG, Tai J, Polyakov I: Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries. Cardiovasc Diabetol. 2012, 11: 75-10.1186/1475-2840-11-75.PubMedCentralCrossRefPubMed Sheehy A, Hsu S, Bouchard A, Lema P, Savard C, Guy LG, Tai J, Polyakov I: Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries. Cardiovasc Diabetol. 2012, 11: 75-10.1186/1475-2840-11-75.PubMedCentralCrossRefPubMed
7.
go back to reference Chong ZZ, Maiese K: Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc Diabetol. 2012, 11: 45-10.1186/1475-2840-11-45.PubMedCentralCrossRefPubMed Chong ZZ, Maiese K: Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc Diabetol. 2012, 11: 45-10.1186/1475-2840-11-45.PubMedCentralCrossRefPubMed
8.
go back to reference Westerweel PE, van Velthoven CT, Nguyen TQ, den Ouden K, de Kleijn DP, Goumans MJ, Goldschmeding R, Verhaar MC: Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol. 2010, 9: 5-10.1186/1475-2840-9-5.CrossRef Westerweel PE, van Velthoven CT, Nguyen TQ, den Ouden K, de Kleijn DP, Goumans MJ, Goldschmeding R, Verhaar MC: Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model. Cardiovasc Diabetol. 2010, 9: 5-10.1186/1475-2840-9-5.CrossRef
9.
go back to reference Zhang XW, Wang Y, Cai JB, Hou XF, Wang HG, Zou JG, Cao KJ: Downregulation of quinone reductase 2 attenuates vascular smooth muscle cells proliferation and neointimal formation in balloon injured rat carotid artery. Cell Physiol Biochem. 2012, 29 (3–4): 453-462.CrossRefPubMed Zhang XW, Wang Y, Cai JB, Hou XF, Wang HG, Zou JG, Cao KJ: Downregulation of quinone reductase 2 attenuates vascular smooth muscle cells proliferation and neointimal formation in balloon injured rat carotid artery. Cell Physiol Biochem. 2012, 29 (3–4): 453-462.CrossRefPubMed
10.
go back to reference Cappella P, Gasparri F, Pulici M, Moll J: A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A. 2008, 73 (7): 626-636.CrossRefPubMed Cappella P, Gasparri F, Pulici M, Moll J: A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A. 2008, 73 (7): 626-636.CrossRefPubMed
11.
go back to reference Buck SB, Bradford J, Gee KR, Agnew BJ, Clarke ST, Salic A: Detection of S-phase cell cycle progression using 5-ethynyl-2′-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2′-deoxyuridine antibodies. Biotechniques. 2008, 44 (7): 927-929. 10.2144/000112812.CrossRefPubMed Buck SB, Bradford J, Gee KR, Agnew BJ, Clarke ST, Salic A: Detection of S-phase cell cycle progression using 5-ethynyl-2′-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2′-deoxyuridine antibodies. Biotechniques. 2008, 44 (7): 927-929. 10.2144/000112812.CrossRefPubMed
12.
go back to reference Tornøe CW, Christensen C, Meldal M: Peptidotriazoles on solid phase: [1-3]-Triazoles by regiospecific copper (i)-catalyzed 1, 3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem. 2002, 67 (9): 3057-3064. 10.1021/jo011148j.CrossRefPubMed Tornøe CW, Christensen C, Meldal M: Peptidotriazoles on solid phase: [1-3]-Triazoles by regiospecific copper (i)-catalyzed 1, 3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem. 2002, 67 (9): 3057-3064. 10.1021/jo011148j.CrossRefPubMed
13.
go back to reference Rostovtsev VV, Green LG, Fokin VV, Sharpless KB: A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ''ligation'' of azides and terminal alkynes. Angew Chem Int Ed Engl. 2002, 41 (14): 2596-2599. 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4.CrossRefPubMed Rostovtsev VV, Green LG, Fokin VV, Sharpless KB: A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ''ligation'' of azides and terminal alkynes. Angew Chem Int Ed Engl. 2002, 41 (14): 2596-2599. 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4.CrossRefPubMed
14.
go back to reference Diermeier-Daucher S, Brockhoff G: Dynamic proliferation assessment in flow cytometry. Curr Protoc Cell Biol. 2010, Chapter 8 (Unit 8.6): 1-23. Diermeier-Daucher S, Brockhoff G: Dynamic proliferation assessment in flow cytometry. Curr Protoc Cell Biol. 2010, Chapter 8 (Unit 8.6): 1-23.
15.
go back to reference Diermeier-Daucher S, Clarke ST, Hill D, Vollmann-Zwerenz A, Bradford JA, Brockhoff G: Cell type specific applicability of 5-ethnyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry. Cytometry A. 2009, 75 (6): 535-546.CrossRefPubMed Diermeier-Daucher S, Clarke ST, Hill D, Vollmann-Zwerenz A, Bradford JA, Brockhoff G: Cell type specific applicability of 5-ethnyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry. Cytometry A. 2009, 75 (6): 535-546.CrossRefPubMed
16.
go back to reference McGowan EM, Alling N, Jackson EA, Yagoub D, Haass NK, Allen JD, Martinello-Wilks R: Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay. PLoS One. 2011, 6 (6): e20623-10.1371/journal.pone.0020623.PubMedCentralCrossRefPubMed McGowan EM, Alling N, Jackson EA, Yagoub D, Haass NK, Allen JD, Martinello-Wilks R: Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay. PLoS One. 2011, 6 (6): e20623-10.1371/journal.pone.0020623.PubMedCentralCrossRefPubMed
17.
go back to reference Yu Y, Arora A, Min W, Roifman CM, Grunebaum E: EdU incorporation is an alternative non-radioactive assay to [3H]thymidine uptake for in vitro measurement of mice T-cell proliferations. J Immunol Methods. 2009, 350 (1–2): 29-35.CrossRefPubMed Yu Y, Arora A, Min W, Roifman CM, Grunebaum E: EdU incorporation is an alternative non-radioactive assay to [3H]thymidine uptake for in vitro measurement of mice T-cell proliferations. J Immunol Methods. 2009, 350 (1–2): 29-35.CrossRefPubMed
18.
go back to reference Salic A, Mitchison TJ: A chemical method for fast and sensitive detection of DNA synthesis in vivo. PNAS. 2008, 105 (7): 2415-2420. 10.1073/pnas.0712168105.PubMedCentralCrossRefPubMed Salic A, Mitchison TJ: A chemical method for fast and sensitive detection of DNA synthesis in vivo. PNAS. 2008, 105 (7): 2415-2420. 10.1073/pnas.0712168105.PubMedCentralCrossRefPubMed
19.
go back to reference Kaiser CL, Kamien AJ, Shah PA, Chapman BJ, Cotanche DA: 5-Ethynyl-2'-deoxyuridine labeling detects proliferating cells in the regenerating avian cochlea. Laryngoscope. 2009, 119 (9): 1770-1775. 10.1002/lary.20557.PubMedCentralCrossRefPubMed Kaiser CL, Kamien AJ, Shah PA, Chapman BJ, Cotanche DA: 5-Ethynyl-2'-deoxyuridine labeling detects proliferating cells in the regenerating avian cochlea. Laryngoscope. 2009, 119 (9): 1770-1775. 10.1002/lary.20557.PubMedCentralCrossRefPubMed
20.
go back to reference Zeng C, Pan F, Jones LA, Lim MM, Griffin EA, Sheline YI, Mintun MA, Holtzman DM, Mach RH: Evaluation of 5-ethynyl-2′-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system. Brain Res. 2010, 1319: 21-32.CrossRefPubMed Zeng C, Pan F, Jones LA, Lim MM, Griffin EA, Sheline YI, Mintun MA, Holtzman DM, Mach RH: Evaluation of 5-ethynyl-2′-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system. Brain Res. 2010, 1319: 21-32.CrossRefPubMed
22.
go back to reference Zucker LM, Antoniades HN: Insulin and obesity in the Zucker genetically obese rat “fatty”. Endocrinology. 1972, 90 (5): 1320-1330. 10.1210/endo-90-5-1320.CrossRefPubMed Zucker LM, Antoniades HN: Insulin and obesity in the Zucker genetically obese rat “fatty”. Endocrinology. 1972, 90 (5): 1320-1330. 10.1210/endo-90-5-1320.CrossRefPubMed
23.
go back to reference Zhou Z, Penn MS, Forudi F, Zhou X, Tarakji K, Topol EJ, Lincoff AM, Wang K: Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model. Arterioscler Thromb Vasc Biol. 2002, 22 (10): 1598-1603. 10.1161/01.ATV.0000032676.20514.8F.CrossRefPubMed Zhou Z, Penn MS, Forudi F, Zhou X, Tarakji K, Topol EJ, Lincoff AM, Wang K: Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model. Arterioscler Thromb Vasc Biol. 2002, 22 (10): 1598-1603. 10.1161/01.ATV.0000032676.20514.8F.CrossRefPubMed
24.
go back to reference Wang K, Zhou Z, Zhang M, Fan L, Forudi F, Zhou X, Qu W, Lincoff AM, Schmidt AM, Topol EJ, Penn MS: Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther. 2006, 317 (1): 37-43.CrossRefPubMed Wang K, Zhou Z, Zhang M, Fan L, Forudi F, Zhou X, Qu W, Lincoff AM, Schmidt AM, Topol EJ, Penn MS: Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther. 2006, 317 (1): 37-43.CrossRefPubMed
25.
go back to reference Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ: Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation. 2003, 107 (17): 2238-2243. 10.1161/01.CIR.0000063577.32819.23.CrossRefPubMed Zhou Z, Wang K, Penn MS, Marso SP, Lauer MA, Forudi F, Zhou X, Qu W, Lu Y, Stern DM, Schmidt AM, Lincoff AM, Topol EJ: Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Circulation. 2003, 107 (17): 2238-2243. 10.1161/01.CIR.0000063577.32819.23.CrossRefPubMed
26.
go back to reference Park SH, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation. 2001, 104 (7): 815-819. 10.1161/hc3301.092789.CrossRefPubMed Park SH, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation. 2001, 104 (7): 815-819. 10.1161/hc3301.092789.CrossRefPubMed
27.
go back to reference Goto Y, Kakizaki M, Masaki N: Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med. 1976, 119 (1): 85-90. 10.1620/tjem.119.85.CrossRefPubMed Goto Y, Kakizaki M, Masaki N: Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med. 1976, 119 (1): 85-90. 10.1620/tjem.119.85.CrossRefPubMed
28.
go back to reference El-Omar MM, Yang ZK, Phillips AO, Shah AM: Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus. Basic Res Cardiol. 2004, 99 (2): 133-141. El-Omar MM, Yang ZK, Phillips AO, Shah AM: Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus. Basic Res Cardiol. 2004, 99 (2): 133-141.
29.
go back to reference Hurst RT, Lee RW: Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med. 2003, 139 (10): 824-834.CrossRefPubMed Hurst RT, Lee RW: Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med. 2003, 139 (10): 824-834.CrossRefPubMed
30.
go back to reference Nesto RW: Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med. 2004, 116 (suppl 5A): 11S-22S.CrossRefPubMed Nesto RW: Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med. 2004, 116 (suppl 5A): 11S-22S.CrossRefPubMed
31.
go back to reference Lee CD, Folsom AR, Pankow JS, Brancati FL, Atherosclerosis Risk in Communities (ARIC) Study Investigators: Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004, 109 (7): 855-860. 10.1161/01.CIR.0000116389.61864.DE.CrossRefPubMed Lee CD, Folsom AR, Pankow JS, Brancati FL, Atherosclerosis Risk in Communities (ARIC) Study Investigators: Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004, 109 (7): 855-860. 10.1161/01.CIR.0000116389.61864.DE.CrossRefPubMed
32.
go back to reference Hammound T, Tanguay JF, Bourassa MG: Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000, 36 (2): 355-365. 10.1016/S0735-1097(00)00732-4.CrossRef Hammound T, Tanguay JF, Bourassa MG: Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000, 36 (2): 355-365. 10.1016/S0735-1097(00)00732-4.CrossRef
33.
go back to reference Smith SC, Faxon D, Cascio W, Schaff H, Gardner T, Jacobs A, Nissen S, Stouffer R: Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. Circulation. 2002, 105 (18): e165-e169. 10.1161/01.CIR.0000013957.30622.05.CrossRefPubMed Smith SC, Faxon D, Cascio W, Schaff H, Gardner T, Jacobs A, Nissen S, Stouffer R: Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. Circulation. 2002, 105 (18): e165-e169. 10.1161/01.CIR.0000013957.30622.05.CrossRefPubMed
34.
go back to reference Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, Davis BR, Holmes DR: Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of REStenosis with tranilast and its outcomes (PRESTO) trial. Circulation. 2004, 109 (4): 476-480. 10.1161/01.CIR.0000109693.64957.20.CrossRefPubMed Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, Davis BR, Holmes DR: Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of REStenosis with tranilast and its outcomes (PRESTO) trial. Circulation. 2004, 109 (4): 476-480. 10.1161/01.CIR.0000109693.64957.20.CrossRefPubMed
35.
go back to reference Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after interventions is due to exaggerated intimal hyperplasia: A serial intravascular ultrasound study. Circulation. 1997, 95 (6): 1366-1369. 10.1161/01.CIR.95.6.1366.CrossRefPubMed Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after interventions is due to exaggerated intimal hyperplasia: A serial intravascular ultrasound study. Circulation. 1997, 95 (6): 1366-1369. 10.1161/01.CIR.95.6.1366.CrossRefPubMed
36.
go back to reference Kotogány E, Dudits D, Horváth GV, Ayaydin F: A rapid and robust assay for detection of S-phase cell cycle progression in plant cells and tissues by using ethynyl deoxyuridine. Plant Methods. 2010, 6 (1): 5-10.1186/1746-4811-6-5.PubMedCentralCrossRefPubMed Kotogány E, Dudits D, Horváth GV, Ayaydin F: A rapid and robust assay for detection of S-phase cell cycle progression in plant cells and tissues by using ethynyl deoxyuridine. Plant Methods. 2010, 6 (1): 5-10.1186/1746-4811-6-5.PubMedCentralCrossRefPubMed
37.
go back to reference Hua H, Kearsey SE: Monitoring DNA replication in fission yeast by incorporation of 5-ethynyl-2'-deoxyuridine. Nucleic Acids Res. 2011, 39 (9): e60-10.1093/nar/gkr063.PubMedCentralCrossRefPubMed Hua H, Kearsey SE: Monitoring DNA replication in fission yeast by incorporation of 5-ethynyl-2'-deoxyuridine. Nucleic Acids Res. 2011, 39 (9): e60-10.1093/nar/gkr063.PubMedCentralCrossRefPubMed
38.
go back to reference Grenier L, Robaire B, Hales BF: Paternal cyclophosphamide exposure induces the formation of functional micronuclei during the first zygotic division. PLoS One. 2011, 6 (11): e27600-10.1371/journal.pone.0027600.PubMedCentralCrossRefPubMed Grenier L, Robaire B, Hales BF: Paternal cyclophosphamide exposure induces the formation of functional micronuclei during the first zygotic division. PLoS One. 2011, 6 (11): e27600-10.1371/journal.pone.0027600.PubMedCentralCrossRefPubMed
39.
go back to reference Škalamera D, Ranall MV, Wilson BM, Leo P, Purdon AS, Hyde C, Nourbakhsh E, Grimmond SM, Barry SC, Gabrielli B, Gonda TJ: A high-throughput platform for lentiviral overexpression screening of the human ORFeome. PLoS One. 2011, 6 (5): e20057-10.1371/journal.pone.0020057. (2011).PubMedCentralCrossRefPubMed Škalamera D, Ranall MV, Wilson BM, Leo P, Purdon AS, Hyde C, Nourbakhsh E, Grimmond SM, Barry SC, Gabrielli B, Gonda TJ: A high-throughput platform for lentiviral overexpression screening of the human ORFeome. PLoS One. 2011, 6 (5): e20057-10.1371/journal.pone.0020057. (2011).PubMedCentralCrossRefPubMed
40.
go back to reference Pearson RB, Thomas G: Regulation of p70S6K/p85S6K and its role in the cell cycle. Prog Cell Cycle Res. 1995, 1: 21-32.CrossRefPubMed Pearson RB, Thomas G: Regulation of p70S6K/p85S6K and its role in the cell cycle. Prog Cell Cycle Res. 1995, 1: 21-32.CrossRefPubMed
41.
go back to reference Thomas G, Hall MN: Tor signaling and control of cell growth. Curr Opin Cell Biol. 1997, 9: 782-787. 10.1016/S0955-0674(97)80078-6.CrossRefPubMed Thomas G, Hall MN: Tor signaling and control of cell growth. Curr Opin Cell Biol. 1997, 9: 782-787. 10.1016/S0955-0674(97)80078-6.CrossRefPubMed
42.
go back to reference Marx N, Duez H, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res. 2004, 94 (9): 1168-1178. 10.1161/01.RES.0000127122.22685.0A.CrossRefPubMed Marx N, Duez H, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res. 2004, 94 (9): 1168-1178. 10.1161/01.RES.0000127122.22685.0A.CrossRefPubMed
43.
go back to reference Braun-Dullaeus RC, Mann MJ, Seay U, Zhang L, von Der Leyen HE, Morris RE, Dzau VJ: Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol. 2001, 21 (7): 1152-1158. 10.1161/hq0701.092104.CrossRefPubMed Braun-Dullaeus RC, Mann MJ, Seay U, Zhang L, von Der Leyen HE, Morris RE, Dzau VJ: Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol. 2001, 21 (7): 1152-1158. 10.1161/hq0701.092104.CrossRefPubMed
44.
go back to reference Lee CS, Kwon YW, Yang HM, Kim SH, Kim TY, Hur J, Park KW, Cho HJ, Kang HJ, Park YB, Kim HS: New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. Arterioscler Thromb Vasc Biol. 2009, 29 (4): 472-479. 10.1161/ATVBAHA.108.176230.CrossRefPubMed Lee CS, Kwon YW, Yang HM, Kim SH, Kim TY, Hur J, Park KW, Cho HJ, Kang HJ, Park YB, Kim HS: New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. Arterioscler Thromb Vasc Biol. 2009, 29 (4): 472-479. 10.1161/ATVBAHA.108.176230.CrossRefPubMed
Metadata
Title
Detecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine
Authors
Jingsheng Guo
Dongye Li
Shiru Bai
Tongda Xu
Zhongmin Zhou
Yanbin Zhang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-150

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue